Health AI Central
Share:
Peer-Reviewed Publication
Expert Opin Drug Discov2024;19(7):815-825.July 1, 2024Journal Article

Data processing for high-throughput mass spectrometry in drug discovery.

Chang Liu1, Hui Zhang2
1SCIEX, Concord, ON, Canada.
2Iambic Therapeutics, San Diego, CA, USA.
PubMed DOI

Abstract

INTRODUCTION: High-throughput mass spectrometry that could deliver > 10 times faster sample readout speed than traditional LC-based platforms has emerged as a powerful analytical technique, enabling the rapid analysis of complex biological samples. This increased speed of MS data acquisition has brought a critical demand for automatic data processing capabilities that should match or surpass the s…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free AccountSign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.